Saro Armenian, Director of the Division of Outcomes Research, Director of the Center for Survivorship and Outcomes, Hematologic Malignancies Institute, and Barron Hilton Chair and Professor of Pediatrics, Department of Pediatrics at City of Hope, shared a post by June-Wha Rhee, Cardio-oncologist at City of Hope, adding:
“This is such an important initiative! Kudos to June-Wha Rhee, Pradeep Natarajan, and team for putting this important document together. It is a must-read for clinicians and researchers who are interested in understanding the biologic underpinnings of CHIP-associated health outcomes.”
June-Wha Rhee also shared a post by Pradeep Natarajan, Director of Preventive Cardiology at Massachusetts General Hospital adding:
“It was an incredible opportunity to work with such an amazing group of hashtag#CHIP experts! This statement would not have been possible without the leadership and guidance of Pradeep Natarajan and the outstanding contributions and expertise of Lachelle Dawn Weeks, Dipti Gupta, Kelly Bolton, Alan Tall, Alex Bick, José Javier Fuster, and Dr. Kenneth Walsh.
The field is rapidly evolving, and I look forward to seeing even more exciting science ahead.”
Quoting Pradeep Natarajan‘s post:
“Excited to share our American Heart Association Scientific Statement on Clonal Hematopoiesis and Cardiovascular Disease led by June-Wha Rhee.”
Title: Clonal Hematopoiesis and Its Cardiovascular Implications: A Scientific Statement From the American Heart Association
Authors: June-Wha Rhee, Kelly L. Bolton, Dipti Gupta, Lachelle D. Weeks, Alexander G. Bick, Alan R. Tall, Kenneth Walsh, José J. Fuster, Pradeep Natarajan
Read the Full Article.
Other articles featuring Saro Armenian on OncoDaily.
